Commentary on treatment of hypertension in the elderly

Cardiovascular Drugs and Therapy

Volumn 15, Issue 3, 2001, Pages 281-282

  Aronow, W S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Beta blockers; Congestive heart failure; Diabetes mellitus; Diuretics; Hypertension; Myocardial infarction

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; AGING; COMORBIDITY; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRUG CHOICE; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY FAILURE; PRIORITY JOURNAL; PROTEINURIA; TREATMENT INDICATION;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION;

EID: 0034780540     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011980626346     Document Type: Conference Paper

References (15)

1. The sixth report of the Joint National Committee on the detection, evaluation, and treatment of high blood pressure (JNC VI)
2. Drug treatment of hypertension in older persons in an academic hospital-based geriatrics practice
3. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal result of the Hypertension Optimal Treatment (HOT) randomised trial
4. National high blood pressure program working group report on hypertension in the elderly
5. 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
6. Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and diabetes mellitus
7. Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease
8. Effect of propranolol in postinfarction patients with mechanical or electrical complications
9. Beta-blocker therapy in the cardiac arrhythmia suppression trial
10. Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients ≥62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction ≥40%
11. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF)
12. Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction ≥40% treated with diuretics plus angiotensin-converting-enzyme inhibitors
13. Reversal of left ventricular hypertrophy in hypertensive patients: A metaanalysis of 109 treatment studies
14. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
15. Dizziness and syncope